мебели комбайн пренебрегване non ligand estrogen pathway nf kappa fulvestrant антология участник пенсионер
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
EREs).
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
New insights into acquired endocrine resistance of breast cancer
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
New insights into acquired endocrine resistance of breast cancer
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)